CC

The Chemours Company

CCBasic MaterialsNASDAQ

Specialty Chemicals · Last scanned Jul 18, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$5.81B
+0.4% YoY
Net Income
-$386.0M
-659.4% YoY
EBITDA
$332.0M
-49.8% YoY
Free Cash Flow
$216.3M

Scan Results

Daily timeframe
3 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 RSI OversoldRSI 29.0, below 30, stock may be oversold
Jul 10 RSI OversoldRSI 25.0, below 30, stock may be oversold
Below MA2000.8% below MA200
About The Chemours Company

Part of the basic materials sector, The Chemours Company (CC) is listed under Specialty Chemicals. Valued at $2.63B, CC is a mid-cap name in its sector. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials.

Key stats
Market Cap$2.63B
Fwd P/E7.82
EPS$-2.76
Beta1.40
52W Change+29.2%
Dividend Yield2.02%
ROE-103.0%
Analysis

The Chemours Company carries $4.39B in total debt against $563.0M in cash reserves — debt is roughly 7.8x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $216.2M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at -103.0%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.1% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $6.34B (2021) to $5.81B (2025).

Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for The Chemours Company and its sector.

Links
More Basic Materials stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms